Published in Thorax on February 01, 1989
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax (1993) 1.51
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
Dose-response study with high-dose inhaled salmeterol in healthy subjects. Br J Clin Pharmacol (1992) 1.33
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
The current debate concerning beta-agonists in asthma: a review. J R Soc Med (1993) 0.92
Inhaled beta 2-adrenoceptor agonists in asthma: help or hindrance? Br J Clin Pharmacol (1992) 0.92
Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax (1992) 0.84
Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years. Thorax (2001) 0.84
The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. Br J Clin Pharmacol (1998) 0.77
Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions. Clin Exp Immunol (2002) 0.76
Cardiopulmonary interactions of salbutamol and hypoxaemia in healthy young volunteers. Br J Clin Pharmacol (1995) 0.75
Does tachyphylaxis occur to the non-pulmonary effects of salmeterol? Br J Clin Pharmacol (1994) 0.75
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulization. Postgrad Med J (1991) 0.75
The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. Br J Pharmacol (1994) 0.75
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 0.75
Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. Br J Clin Pharmacol (1993) 0.75
Some statistical methods useful in circulation research. Circ Res (1980) 11.88
Investigation into use of drugs preceding death from asthma. Br Med J (1968) 6.76
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46
Torsade De Pointes, an atypical ventricular tachycardia. Br Heart J (1976) 4.22
A critical review of the systolic time intervals. Circulation (1977) 3.34
Bronchodilator drugs. Am Rev Respir Dis (1979) 2.24
Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. Br J Pharmacol (1980) 1.93
Nebulised salbutamol and angina. Br Med J (Clin Res Ed) (1982) 1.81
Cardiac arrhythmias caused by nebulised beta-agonist therapy. Lancet (1987) 1.57
Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol (1987) 1.57
The role of cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist. Clin Pharmacol Ther (1986) 1.23
Systolic time intervals: a review of the method in the non-invasive investigation of cardiac function in health, disease and clinical pharmacology. Postgrad Med J (1983) 1.16
Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest (1980) 1.10
Arrhythmogenic effects of orally administered bronchodilators. Arch Intern Med (1979) 1.07
Sympathomimetic bronchodilator drugs. Pharmacol Ther B (1976) 1.05
Hypokalaemia induced by inhalation of fenoterol. Lancet (1985) 1.02
Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther (1984) 0.96
Why are deaths from asthma increasing? Eur J Respir Dis Suppl (1986) 0.93
Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation. J Thorac Cardiovasc Surg (1978) 0.87
Effects of atropine on diastolic time. Circulation (1981) 0.86
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol (2002) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47
Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust (1990) 1.41
Use of a management plan for treating asthma in an emergency department. Thorax (1990) 1.40
Semantic and associative priming in the cerebral hemispheres: some words do, some words don't ... sometimes, some places. Brain Lang (1990) 1.39
Fenoterol and asthma death. N Z Med J (1989) 1.39
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J (1993) 1.37
The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis (1987) 1.33
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Br Med J (Clin Res Ed) (1985) 1.30
Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol (1995) 1.24
Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax (1999) 1.23
Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy (1992) 1.23
Characterizing semantic space: neighborhood effects in word recognition. Psychon Bull Rev (2001) 1.22
A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial. Br J Cancer (2011) 1.21
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. Postgrad Med J (1990) 1.18
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol (1999) 1.18
A randomised controlled trial of an intervention to promote early presentation of breast cancer in older women: effect on breast cancer awareness. Br J Cancer (2009) 1.16
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health (2001) 1.14
Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J (2003) 1.14
Reduced selenium status of patients with asthma. Clin Sci (Lond) (1989) 1.14
Role of bronchial responsiveness testing in asthma prevalence surveys. Thorax (2000) 1.12
Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J (1993) 1.10
Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. Br J Clin Pharmacol (1988) 1.09